Johnson & Johnson ordered to pay $572 million in opioid trial decision

The Associated Press - August 26, 2019 3:16 pm

NORMAN, Okla. (AP) – An Oklahoma judge has found Johnson & Johnson and its subsidiaries helped fuel the state’s opioid drug crisis and ordered the consumer products giant to pay $572 million to help address the problem.

Cleveland County Judge Thad Balkman issued the decision Monday in the nation’s first state trial against the companies accused of contributing to the widespread use of the highly addictive painkillers.

The company is expected to appeal.

Oklahoma argued the company aggressively marketed opioids for years in a way that overstated their effectiveness and underplayed the addiction risk.

Oklahoma previously reached a $270 million settlement with Oxycontin-maker Purdue Pharma and an $85 million deal with Israeli-owned Teva Pharmaceutical Industries Ltd.

Oklahoma’s case could shape negotiations to resolve roughly 1,500 other opioid lawsuits consolidated before a federal judge in Ohio.

 

Latest Stories

Native American leaders push for boarding school commission

ALBUQUERQUE, N.M. (AP) — U.S. Interior Secretary Deb Haaland says the federal government has a responsibility...

Investigator: DNA could identify 2 Tulsa massacre victims

TULSA, OKLAHOMA (AP) — Investigators seeking to identify victims of the Tulsa Race Massacre have found...

Harvard returns Standing Bear’s tomahawk to Nebraska tribe

BOSTON (AP) — Harvard has returned a tomahawk once owned by a pioneering Native American civil...